GlassScriptPhysician profile
Elise Schrop
NPI 1336400647
$618.76
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $81.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $141.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.90 | 2019-2020 | |
| Intuitive Surgical, INC. | $94.17 | 2019 | |
| Roche Diagnostics Corporation | $65.23 | 2019 | |
| Merck Sharp & Dohme LLC | $42.93 | 2019-2020 | |
| Therapeuticsmd, INC. | $23.59 | 2019 | |
| Abbvie INC. | $23.04 | 2019 | |
| Mission Pharmacal Company | $22.94 | 2019 | |
| Hologic Sales and Service, LLC | $22.47 | 2019 | |
| Exeltis, USA INC. | $19.08 | 2019 | |
| Coopersurgical, INC. | $15.90 | 2020 | |
| Avion Pharmaceuticals | $14.62 | 2019 | |
| Allergan, INC. | $14.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Schrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.